Cadila Healthcare informs about press release

24 Dec 2018 Evaluate

Cadila Healthcare has informed about press release titled ‘Zydus receives approvals from the USFDA for Doxycycline Hyclate Delayed-Release Tablets and Febuxostat Tablets’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

944.25 -2.65 (-0.28%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.